Literature DB >> 27022018

Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.

Alex Braley1, Taekyoung Kwak1, Joel Jules1, Evis Harja1, Ralf Landgraf1, Barry I Hudson2.   

Abstract

The receptor for advanced glycation end products (RAGE) is a multiligand transmembrane receptor that can undergo proteolysis at the cell surface to release a soluble ectodomain. Here we observed that ectodomain shedding of RAGE is critical for its role in regulating signaling and cellular function. Ectodomain shedding of both human and mouse RAGE was dependent on ADAM10 activity and induced with chemical activators of shedding (ionomycin, phorbol 12-myristate 13-acetate, and 4-aminophenylmercuric acetate) and endogenous stimuli (serum and RAGE ligands). Ectopic expression of the splice variant of RAGE (RAGE splice variant 4), which is resistant to ectodomain shedding, inhibited RAGE ligand dependent cell signaling, actin cytoskeleton reorganization, cell spreading, and cell migration. We found that blockade of RAGE ligand signaling with soluble RAGE or inhibitors of MAPK or PI3K blocked RAGE-dependent cell migration but did not affect RAGE splice variant 4 cell migration. We finally demonstrated that RAGE function is dependent on secretase activity as ADAM10 and γ-secretase inhibitors blocked RAGE ligand-mediated cell migration. Together, our data suggest that proteolysis of RAGE is critical to mediate signaling and cell function and may therefore emerge as a novel therapeutic target for RAGE-dependent disease states.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ADAM; S100 proteins; cell migration; cell signaling; ectodomain shedding; matrix metalloproteinase (MMP); receptor for advanced glycation end products (RAGE)

Mesh:

Substances:

Year:  2016        PMID: 27022018      PMCID: PMC4933258          DOI: 10.1074/jbc.M115.702399

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

Review 2.  Function of ERBB4 is determined by alternative splicing.

Authors:  Ville Veikkolainen; Katri Vaparanta; Kalle Halkilahti; Kristiina Iljin; Maria Sundvall; Klaus Elenius
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

3.  Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium.

Authors:  Ke Zen; Celia X-J Chen; Yi-Tien Chen; Rosemarie Wilton; Yuan Liu
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

4.  Multiple sequence alignment using ClustalW and ClustalX.

Authors:  Julie D Thompson; Toby J Gibson; Des G Higgins
Journal:  Curr Protoc Bioinformatics       Date:  2002-08

5.  Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling.

Authors:  Anastasia Z Kalea; Fiona See; Evis Harja; Maria Arriero; Ann Marie Schmidt; Barry I Hudson
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

6.  Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

Authors:  Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Maria P Buzzi; Chiara Belvito; Mariaclara Cuccia; Diego Geroldi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

7.  Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.

Authors:  J S Huang; J Y Guh; H C Chen; W C Hung; Y H Lai; L Y Chuang
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

8.  Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.

Authors:  M Suganuma; H Fujiki; H Furuya-Suguri; S Yoshizawa; S Yasumoto; Y Kato; N Fusetani; T Sugimura
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

9.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

10.  Identification, classification, and expression of RAGE gene splice variants.

Authors:  Barry I Hudson; Angela M Carter; Evis Harja; Anastasia Z Kalea; Maria Arriero; Hojin Yang; Peter J Grant; Ann Marie Schmidt
Journal:  FASEB J       Date:  2007-12-18       Impact factor: 5.191

View more
  7 in total

1.  Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.

Authors:  Tina E Brinkley; Xiaoyan Leng; Barbara J Nicklas; Stephen B Kritchevsky; Jingzhong Ding; Dalane W Kitzman; W Gregory Hundley
Journal:  Metabolism       Date:  2017-02-10       Impact factor: 8.694

Review 2.  RAGE Signaling in Skeletal Biology.

Authors:  Lilian I Plotkin; Alyson L Essex; Hannah M Davis
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

Review 3.  Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.

Authors:  D Dreymueller; K Theodorou; M Donners; A Ludwig
Journal:  Mediators Inflamm       Date:  2017-02-05       Impact factor: 4.711

4.  Mouse Specific Cleavage-Resistant RAGE Splice Variant.

Authors:  Tohru Fukai
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

Review 5.  How Mouse Macrophages Sense What Is Going On.

Authors:  Klaus Ley; Akula Bala Pramod; Michael Croft; Kodi S Ravichandran; Jenny P Ting
Journal:  Front Immunol       Date:  2016-06-02       Impact factor: 7.561

Review 6.  Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.

Authors:  Massimo De Martinis; Lia Ginaldi; Maria Maddalena Sirufo; Giovanni Pioggia; Gioacchino Calapai; Sebastiano Gangemi; Carmen Mannucci
Journal:  Medicina (Kaunas)       Date:  2020-03-19       Impact factor: 2.430

Review 7.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.